Welcome to our dedicated page for Align Technology SEC filings (Ticker: ALGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Align Technology, Inc. (NASDAQ: ALGN) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a global medical device manufacturer focused on the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, Align uses its SEC filings to report financial performance, governance changes, and other material events.
Investors can use this page to review current reports on Form 8-K, which in the provided examples include announcements of quarterly financial results and updates on executive and board changes. These filings often reference detailed press releases that discuss revenues, clear aligner case volumes, imaging systems and CAD/CAM services revenues, operating margins, restructuring charges, stock repurchases, and business outlook.
In addition to 8-Ks, users can expect to find annual reports on Form 10-K and quarterly reports on Form 10-Q (when available), which typically contain audited or reviewed financial statements, segment information, risk factors, and management’s discussion and analysis. For a company like Align in the medical device and digital dentistry space, these periodic reports are key sources for understanding trends in clear aligner volumes, adoption of iTero scanners and exocad software, and regional performance.
Stock Titan enhances the filings view with AI-powered summaries that explain complex sections of lengthy documents, helping users quickly identify items such as restructuring disclosures, research and development discussion, or references to intellectual property and legal proceedings. The page also surfaces insider transaction filings on Form 4 when available, allowing users to track reported purchases or sales of ALGN shares by directors and officers. Together, these tools help investors and researchers navigate Align Technology’s regulatory history and ongoing reporting obligations more efficiently.
BlackRock, Inc. reports beneficial ownership of 4,113,442 shares of Align Technology common stock, representing 5.7% of the outstanding class as of 12/31/2025. BlackRock has sole voting power over 3,858,169 shares and sole dispositive power over 4,113,442 shares, with no shared voting or dispositive power.
The filing states that these securities are held by certain BlackRock business units in the ordinary course of business and not for the purpose of changing or influencing control of Align Technology. Various underlying persons have rights to dividends or sale proceeds, but no single person has an interest in more than five percent of Align Technology’s common shares.
Align Technology (ALGN) reported Q3 results with net revenues of $995.7 million and net income of $56.8 million. Diluted EPS was $0.78 versus $1.55 a year ago as costs rose and one‑time items weighed on results.
Gross profit was $639.2 million on cost of net revenues of $356.5 million. Operating expenses were $542.9 million, including $31.8 million of restructuring and other charges. The quarter also included a $23.1 million impairment on assets held for sale and a $14.9 million inventory impairment. Effective tax rate was 40.1%.
By segment, Clear Aligner revenue was $805.8 million and Systems & Services was $189.9 million. Geographically, revenue was $410.6 million in the U.S., $210.8 million in Switzerland, and $374.3 million in other international markets.
Cash and cash equivalents were $1.00 billion, deferred revenues totaled $1.38 billion, and shares outstanding were 71,749,995 as of October 29, 2025. Year‑to‑date, the company repurchased $371.6 million of stock and has $928.4 million remaining under the April 2025 authorization. Align paid $31.75 million into escrow for a preliminarily approved settlement.
Align Technology furnished an 8-K under Item 2.02 announcing it issued a press release and will hold a conference call regarding its financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1, and a Cover Page Interactive Data File is embedded as Exhibit 104. The company notes this information is being furnished, not filed, under the Exchange Act.
Align Technology, Inc. disclosed that it has terminated the employment of Mr. Stuart Hockridge, its Executive Vice President, Global Human Resources, with the termination effective in May 2026. The company states that the termination is not for “cause” under his May 23, 2016 employment agreement. Any severance, compensation, or benefits he receives will be materially consistent with that agreement and with the disclosures under “Termination Unrelated to a Change of Control” in Align’s 2025 proxy statement filed on April 8, 2025.
Align Technology (ALGN) Q2 2025 10-Q highlights:
- Revenue: $1.01 bn, -1.6% YoY; Clear Aligner -3.3%, Systems & Services +5.6%.
- Margin: Gross margin 70.0% (70.2% LY); operating margin 16.1% vs 14.3% on lower legal costs.
- Earnings: Net income $124.6 m (+29%), diluted EPS $1.72 (+34%). Six-month EPS $2.98 (+11%).
- Cash & Liquidity: Cash & equivalents $901 m (-14% YTD); no debt; operating cash flow $181 m (-4%).
- Capital return: Completed $1 bn Jan-23 buyback; repurchased 1.34 m shares for $225 m in H1; new $1 bn Apr-25 program with $200 m OMR slated for H2.
- Share count: 72.5 m outstanding (-3.5% YoY).
- Legal/one-offs: Recorded $4.2 m additional accrual toward $31.75 m Section-1 antitrust settlement (prelim approval 5/28/25); VAT dispute with UK HMRC refunded ~$100 m but subject to appeal.
- Segment profit: Clear Aligner op-profit $267 m (-11%); Systems & Services $86 m (+21%).
- Balance sheet: Inventories $243.8 m (-4% YTD); goodwill now $491 m after Cubicure acquisition.
- Tax: Effective rate 28.2% vs 32.9%.
Key takeaways: Despite modest top-line contraction, disciplined expense control, share buybacks and favorable other income drove double-digit EPS growth. Cash burn and continuing legal/tax uncertainties temper outlook, but new $1 bn authorization reinforces management’s confidence.